“News neutrality by unbiased coverage”
One News Page
"Lung Cancer" News 

2018 Report on Biomarker Deals, Covering 2008-2018: Terms, Value and Trends - Features bioMerieux, Integragen, MDX Health, Myriad Genetics, Protagen and Qiagen

Dublin, Dec. 17, 2018 (GLOBE NEWSWIRE) -- The "Biomarker Deals: Terms, Value and Trends, 2008-2018" report has been added to *'s* offering. This report represents a current and..
Credit: GlobeNewswire - Published

Interpace Announces Notice of Allowance from U.S. Patent and Trademark Office Covering BarreGEN®

*BarreGEN® **is Interpace’s Lead Molecular Diagnostic * *Pipeline Product for Barrett’s Esophagus* Parsippany, NJ, Dec. 17, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc...
Credit: GlobeNewswire - Published

Videos for "Lung Cancer"

Cancer immunotherapy duo win 2018 Nobel Prize for Medicine [Video]Cancer immunotherapy duo win 2018 Nobel Prize for Medicine  01:27

STOCKHOLM, SWEDEN — The 2018 Nobel Prize in Physiology or Medicine was awarded to James P. Allison and Tasuku Honjo for their work in harnessing the body's immune system to fight against..

Credit: TomoNews US - Published

Is Delhi's air causing lung cancer? [Video]Is Delhi's air causing lung cancer?  01:44

Lung cancer in the Indian capital rose by 50% between 1988 and 2012.

Credit: BBC World News - Affiliate - Published

VIDEO: Health Beat: Veran Spin's Thoracic Navigation System [Video]VIDEO: Health Beat: Veran Spin's Thoracic Navigation System 

VIDEO: Health Beat: Veran Spin's Thoracic Navigation System

Credit: WFMZ Allentown, PA - Published

FDA Approves Drug That Targets Cancers Based On DNA [Video]FDA Approves Drug That Targets Cancers Based On DNA  00:37

FDA Approves Drug That Targets Cancers Based On DNA

Credit: Wochit News - Published

Fighting lung cancer among non-smokers [Video]Fighting lung cancer among non-smokers  01:43

is smoking. But not everyone who gets lung cancer. Take Tim Kimmel and Keasha Draft, wife of former NFL linebacker Chris Draft. When Draft’s wife died, he started a non-profit, the Chris Draft..

Credit: Rumble - Published

Cancer Patients Face Significantly Higher Risk Of Death From Common Heart Procedure [Video]Cancer Patients Face Significantly Higher Risk Of Death From Common Heart Procedure  00:57

Patients with cancer who undergo a common heart procedure often die from post-surgical complications. According to UPI, researchers from Keene University studied 660,000 patients who received a..

Credit: Wochit - Published


The $65+ Bn Global Market for Immune Checkpoint Inhibitors (2018-2025): Growth Opportunities in the Emerging Markets

Dublin, Dec. 17, 2018 (GLOBE NEWSWIRE) -- The "Immune Checkpoint Inhibitors Market by Type and Application - Global Opportunity Analysis and Industry Forecast, 2018-2025" report has been added to..
Credit: GlobeNewswire - Published

Guardant Health Partners with AstraZeneca to Develop Blood-Based Companion Diagnostic Tests for Tagrisso and Imfinzi

FDA grants breakthrough device designation to GuardantOMNI test used for plasma-based tumor mutational burden analysis in AstraZeneca trial Agreement covers immunotherapy and targeted therapy..
Credit: GlobeNewswire - Published

Visiongain launches a new pharma report: ‘Checkpoint Inhibitors for Treating Cancer Market Report 2018-2028: Analysing Prospects for PD-1 Inhibitors, CLTA-4 Inhibitors and Pipeline Drugs’

LONDON, Dec. 13, 2018 (GLOBE NEWSWIRE) -- Checkpoint inhibitors are significant because they utilise the greatest tool that the body has to fight cancer - its own immune defence system. Checkpoint..
Credit: GlobeNewswire - Published

Inspire’s Health Profiles Identifies the Insights of Patients to Unlock Research Gaps

Company invites new global academic collaborations to accelerate clinical research ARLINGTON, Va., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Inspire, the leading healthcare social network for patients and..
Credit: GlobeNewswire - Published

'A disturbing complacency': losing focus on tobacco control

Nearly 200,000 Australians will die of lung cancer within 20 years, the vast majority smokers. If governments don't refocus, the death rate will be much worse.
Credit: Brisbane Times - Published Also reported by •Sydney Morning HeraldThe Age

ProLung Announces Voting Results from its 2018 Annual Meeting of Shareholders

*SALT LAKE CITY, UT / ACCESSWIRE / December 13, 2018 / *ProLung, Inc. (''ProLung'' or the ''Company'') is focused on reducing the time to diagnosis for lung cancer patients. ProLung^® conducted its..
Credit: Accesswire - Published

Innovent Announces Two Clinical Studies with the Anti-VEGF Monoclonal Antibody IBI305, a Biosimilar Candidate to Avastin (Bevacizumab), Met Primary Endpoints

innovent announces two clinical studies with the anti-vegf monoclonal antibody ibi305, a biosimilar candidate to avastin (bevacizumab), met primary endpoints
SUZHOU, China, Dec. 13, 2018 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class China-based biopharmaceutical company that develops and commercializes high quality drugs,..
Credit: PR Newswire Asia - Published

Precision Cancer Diagnostic Tests: Products & Procedures - Global Market Analysis & Outlook to 2023

Dublin, Dec. 12, 2018 (GLOBE NEWSWIRE) -- The "World Market for Precision Cancer Diagnostic Tests" report has been added to *'s* offering.*World Market for Precision Cancer..
Credit: GlobeNewswire - Published

Genprex boosts outreach to investors with planned launch of corporate website

Gene-therapy company Genprex Inc (NASDAQ:GNPX) is boosting its outreach efforts to investors with the launch of a corporate website in 2019 and new email alerts. The new site will include..
Credit: Proactive Investors - Published

Sunshine Biopharma Signs an Agreement with Crocus Laboratories for Manufacturing of Adva-27a Anticancer Drug

sunshine biopharma signs an agreement with crocus laboratories for manufacturing of adva-27a anticancer drug
*MONTREAL, QC / ACCESSWIRE / December 12, 2018 /* Sunshine Biopharma, Inc. (OTC PINK: SBFM), a pharmaceutical company focused on the research, development and commercialization of drugs for the..
Credit: Accesswire - Published

Preclinical Data on Vaccinex, Inc. Anti-SEMA4D Monoclonal Antibody in Combination with Checkpoint Inhibitors Published in Cancer Immunology Research

ROCHESTER, N.Y., Dec. 12, 2018 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company engaged in the discovery and development of targeted biotherapeutics to treat..
Credit: GlobeNewswire - Published

Zai Lab Announces Acceptance of NDA Submission of ZEJULA (Niraparib) in Mainland China by the NMPA

SHANGHAI, China, Dec. 12, 2018 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB), a Shanghai-based innovative commercial stage biopharmaceutical company, today announced that the China National..
Credit: GlobeNewswire - Published

NHS waiting lists for lung and bowel treatments double since Conservative-led government came to power, analysis shows

Patients waiting for treatment thoracic medicine, used for lung cancer, asthma and tuberculosis, up 128 per cent since 2011, as waits increase across the board
Credit: Independent - Published

Aeglea BioTherapeutics Announces Design of Pivotal Phase 3 PEACE Trial Evaluating Pegzilarginase in Arginase 1 Deficiency

Single, Global Pivotal Trial to Support Registration; Primary Endpoint of Arginine ReductionExpected to Initiate in Q2 2019; Topline Data Anticipated in Q1 2021 Company to Host Conference Call Today..
Credit: GlobeNewswire - Published

North America Patient Monitoring Device Market Outlook 2018-2024 Featuring major Players - Smith's Medical, Medtronic, GE Healthcare and Abbott

Dublin, Dec. 11, 2018 (GLOBE NEWSWIRE) -- The "North America Patient (Human) Monitoring Device Market Outlook 2024" report has been added to *'s* offering. The North America..
Credit: GlobeNewswire - Published

OSE Immunotherapeutics Invited to Present Mechanistic Data on Clinical Stage Anti-Interleukin-7 Receptor Antagonist OSE-127 at Two International Scientific Conferences

*Data presented at the Annual World Congress of Digestive Disease in Rome, Nov. 30 - Dec. 2, and at the Antigen-Specific Immune Tolerance Europe Summit in London, Dec. 10 - 12*· *Presentations..
Credit: GlobeNewswire - Published

CBT Pharmaceuticals and Strata Oncology Announce Collaboration to Accelerate Development of CBT-101, a c-Met inhibitor, for Patients with Non-Small Cell Lung Cancer and other Solid Tumors

PLEASANTON, Calif., HANGZHOU, China and ANN ARBOR, Mich., Dec. 10, 2018 (GLOBE NEWSWIRE) -- CBT Pharmaceuticals (CBT), Inc., a U.S. and China-based innovative pharmaceutical company, and Strata..
Credit: GlobeNewswire - Published

Shahid P. Malik, M.D., Joins The Oncology Institute of Hope and Innovation

The Oncology Institute of Hope and Innovation welcomes Shahid P. Malik, M.D., to their team of specialists. CERRITOS, Calif. (PRWEB) December 10, 2018 Dr. Shahid P. Malik is a board certified..
Credit: PRWeb - Published

You Might Like

 Page 1  〉 
Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2018 One News Page Ltd. All Rights Reserved.
About us  |  Contact us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Contact us  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter  •  FOLLOW us on Pinterest